| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2018 | A Agilent Technologies, Inc. | Koh Boon Hwee | Director | Sell | 6,931 | $66.38 | $460,099.19 | -7.7% | |
| Jun 11, 2018 | WST West Pharmaceutical Services Inc | Malone Daniel | Vice President &Controller | Sell | 5,000 | $97.24 | $486,200.00 | -14.7% | |
| Jun 11, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.22 | $42,200.00 | +0.3% | |
| Jun 11, 2018 | RDNT Radnet, Inc. | Linden Jeffrey L | Executive Vice President | Sell | 10,000 | $12.97 | $129,700.00 | -1.1% | |
| Jun 11, 2018 | A Agilent Technologies, Inc. | Fields Heidi | Director | Sell | 5,000 | $66.48 | $332,375.00 | -8.7% | |
| Jun 8, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 10,000 | $12.81 | $128,100.00 | -3.1% | |
| Jun 8, 2018 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 700 | $595.00 | $416,500.00 | -20.1% | |
| Jun 8, 2018 | WST West Pharmaceutical Services Inc | Federici William J | Sr. VP &CFO | Sell | 42,869 | $96.09 | $4,119,282.21 | -15.8% | |
| Jun 8, 2018 | MYGN Myriad Genetics Inc | Langer Dennis63 | Director | Sell | 20,369 | $39.35 | $801,594.13 | -14.6% | |
| Jun 7, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.04 | $40,400.00 | +0.3% | |
| Jun 7, 2018 | MTD Mettler Toledo International Inc/ | Heidingsfelder Michael | Head Of Industrial | Sell | 2,562 | $590.00 | $1,511,580.00 | -100% | |
| Jun 7, 2018 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 5,355 | $582.80 | $3,120,900.00 | -23.6% | |
| Jun 7, 2018 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 1,150 | $587.83 | $676,000.00 | -17.1% | |
| Jun 6, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 30,000 | $4.05 | $121,500.00 | +0.3% | |
| Jun 6, 2018 | MYGN Myriad Genetics Inc | Gilbert Walter Phd | Director | Sell | 30,000 | $39.69 | $1,190,588.78 | -35.5% | |
| Jun 5, 2018 | MYGN Myriad Genetics Inc | Langer Dennis63 | Director | Sell | 49,631 | $39.30 | $1,950,276.90 | -23.8% | |
| Jun 4, 2018 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 2,500 | $212.00 | $530,000.00 | -6.3% | |
| Jun 1, 2018 | WAT Waters Corp /de/ | Harrington Michael C | SVP, Global Markets | Sell | 15,000 | $194.64 | $2,919,600.00 | -88.0% | |
| Jun 1, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 230,533 | $12.12 | $2,794,059.96 | -7.7% | |
| May 31, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,900 | $3.76 | $14,664.00 | +0.1% | |
| May 31, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 169,467 | $11.68 | $1,979,736.32 | -1.8% | |
| May 30, 2018 | MYGN Myriad Genetics Inc | Langer Dennis63 | Director | Sell | 10,000 | $37.92 | $379,245.00 | -20.1% | |
| May 30, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 33,139 | $38.00 | $1,259,282.00 | -21.1% | |
| May 30, 2018 | MYGN Myriad Genetics Inc | Capone Mark Christopher | President &C.e.o. | Sell | 90,000 | $38.00 | $3,420,000.00 | -21.3% | |
| May 29, 2018 | NEO Neogenomics Inc | Balliet Jennifer | VP And Chief Culture Officer | Sell | 65,000 | $11.66 | $758,100.00 | -51.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.